Scholarlink

<p>The research examines the role of the pharmaceutical industry in achieving Sustainable Development Goal 9 in the low- and middle-income countries (LMICs). The economic and environmental aspects of pharmaceutical industrialization are measured with the help of two composite measures: Sustainability in pharmaceutical industry (SPI) and Pharmaceutical Economic performance Index. The endogeneity, the dynamics of time, and heterogeneity of countries are tackled using a dynamic System Generalized Method of Moments model that is estimated using ten LMICs panel data covering timeframe of 2013–2023. Findings indicate that sustainability remains an issue that persists: a lagged SPI (SPI <sub>t−1</sub>) has a positive influence on the present sustainability. Sustainability is also increased with economic performance and foreign direct investment and a detrimental effect is exerted by urbanization. Significant positive results are evident in the Government environmental taxes and the government expenditure on environmental protection. These results put a major emphasis on the roles played by industrial performance, policy tools, and technological transfer to enhance sustainable pharmaceutical industrialization in LMICs.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The role of the pharmaceutical industry in achieving SDG 9 in low- and middle-income countries

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月19日

查看全文
  • Hafsa Taqqadus,
  • Alam Khan,
  • Dilawar Khan,
  • Robert Magda

摘要

The research examines the role of the pharmaceutical industry in achieving Sustainable Development Goal 9 in the low- and middle-income countries (LMICs). The economic and environmental aspects of pharmaceutical industrialization are measured with the help of two composite measures: Sustainability in pharmaceutical industry (SPI) and Pharmaceutical Economic performance Index. The endogeneity, the dynamics of time, and heterogeneity of countries are tackled using a dynamic System Generalized Method of Moments model that is estimated using ten LMICs panel data covering timeframe of 2013–2023. Findings indicate that sustainability remains an issue that persists: a lagged SPI (SPI t−1) has a positive influence on the present sustainability. Sustainability is also increased with economic performance and foreign direct investment and a detrimental effect is exerted by urbanization. Significant positive results are evident in the Government environmental taxes and the government expenditure on environmental protection. These results put a major emphasis on the roles played by industrial performance, policy tools, and technological transfer to enhance sustainable pharmaceutical industrialization in LMICs.